
MedTech Innovator is the world’s largest accelerator for medical device, digital health, and diagnostic companies, supporting promising medical technology startups through mentorship, strategic industry partnerships, and access to a global network of investors, healthcare leaders, and industry experts. The highly competitive 2026 program selected 65 companies from thousands of applicants worldwide.
During the program, Tau Medical was also selected as one of five finalists for the 2026 Mid-Stage Grand Prize, recognizing its development of Pivot Extend®, a minimally invasive transcatheter tricuspid repair spacer designed to treat tricuspid regurgitation while preserving the heart’s native anatomy.
The Nasdaq Tower celebration marked the conclusion of the 2026 accelerator program and highlighted the achievements of its graduating companies. Tau Medical is honored to be recognized among this year’s innovators and looks forward to building on the relationships and opportunities developed through the MTI program.
Learn more about MedTech Innovator: https://medtechinnovator.org/